Related Experiment Video
Updated: Jan 7, 2026

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis
Published on: June 27, 2020
Origin recognition complex subunit 1 functions as an oncogenic driver and therapeutic target in cancer
Yixuan Ding1, Shiwei Cai2, Jinzhou Cai3
1Department of Intensive Care, The Nanhua Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
None:
ORC1 is a core protein governing DNA replication initiation and cell cycle regulation, exhibiting significant overexpression in multiple malignancies where it correlates with advanced disease stage and poor prognosis. It drives tumor progression through diverse mechanisms including activation of ERK/JNK and Wnt signaling pathways, inhibition of ferroptosis via SLC7A11, and promotion of epithelial-mesenchymal transition. Its expression is regulated through multiple layers including m6A modification by IGF2BP1, the XIST/miR-140-5p axis, transcription factors like ETV4, and epigenetic regulators including EZH2. ORC1 represents a promising therapeutic target, as its inhibition induces replication stress, cell cycle arrest, and enhances sensitivity to existing chemotherapeutic agents. Future research should focus on developing specific ORC1 inhibitors and exploring their synergistic potential with immunotherapy and targeted therapies.
Related Concept Videos
Abnormal Proliferation
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Targeted Cancer Therapies
There are several types of targeted therapies against...
Mitogens and the Cell Cycle

